极品新婚夜少妇真紧,亚洲精品一区二区三区中文字幕 ,久久久久人妻精品一区三寸蜜桃,日韩人妻无码一区二区三区

產(chǎn)品資料

Norrie Disease, Recombinant Protein

如果您對(duì)該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱: Norrie Disease, Recombinant Protein
產(chǎn)品型號(hào):
產(chǎn)品展商: 其他品牌
產(chǎn)品文檔: 無相關(guān)文檔

簡單介紹

Norrie Disease, Recombinant Protein


Norrie Disease, Recombinant Protein  的詳細(xì)介紹
Product Name

Norrie Disease (NDP), Recombinant Protein

Full Product Name

Recombinant Human Norrie Disease

Product Synonym Names
NDP Human; Norrie Disease Human Recombinant; 800x600 Norrin; EVR2; FEVR; ND; Norrie disease protein; X-linked exudative vitreoretinopathy 2 protein; NDP; Norrie Disease. Normal 0 false false false EN-US X-NONE HE MicrosoftInternetExplorer4 DefSemiHidden="true" DefQFormat="false" DefPriority="99" LatentStyleCount="267"> UnhideWhenUsed="false" QFormat="true" Name="Normal"/> UnhideWhenUsed="false" QFormat="true" Name="heading 1"/> UnhideWhenUsed="false" QFormat="true" Name="Title"/> UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/> UnhideWhenUsed="false" QFormat="true" Name="Strong"/> UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/> UnhideWhenUsed="false" Name="Table Grid"/> UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/> UnhideWhenUsed="false" Name="Light Shading"/> UnhideWhenUsed="false" Name="Light List"/> UnhideWhenUsed="false" Name="Light Grid"/> UnhideWhenUsed="false" Name="Medium Shading 1"/> UnhideWhenUsed="false" Name="Medium Shading 2"/> UnhideWhenUsed="false" Name="Medium List 1"/> UnhideWhenUsed="false" Name="Medium List 2"/> UnhideWhenUsed="false" Name="Medium Grid 1"/> UnhideWhenUsed="false" Name="Medium Grid 2"/> UnhideWhenUsed="false" Name="Medium Grid 3"/> UnhideWhenUsed="false" Name="Dark List"/> UnhideWhenUsed="false" Name="Colorful Shading"/> UnhideWhenUsed="false" Name="Colorful List"/> UnhideWhenUsed="false" Name="Colorful Grid"/> UnhideWhenUsed="false" Name="Light Shading Accent 1"/> UnhideWhenUsed="false" Name="Light List Accent 1"/> UnhideWhenUsed="false" Name="Light Grid Accent 1"/> UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/> UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/> UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/> UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/> UnhideWhenUsed="false" QFormat="true" Name="Quote"/> UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/> UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/> UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/> UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/> UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/> UnhideWhenUsed="false" Name="Dark List Accent 1"/> UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/> UnhideWhenUsed="false" Name="Colorful List Accent 1"/> UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/> UnhideWhenUsed="false" Name="Light Shading Accent 2"/> UnhideWhenUsed="false" Name="Light List Accent 2"/> UnhideWhenUsed="false" Name="Light Grid Accent 2"/> UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/> UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/> UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/> UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/> UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/> UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/> UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/> UnhideWhenUsed="false" Name="Dark List Accent 2"/> UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/> UnhideWhenUsed="false" Name="Colorful List Accent 2"/> UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/> UnhideWhenUsed="false" Name="Light Shading Accent 3"/> UnhideWhenUsed="false" Name="Light List Accent 3"/> UnhideWhenUsed="false" Name="Light Grid Accent 3"/> UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/> UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/> UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/> UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/> UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/> UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/> UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/> UnhideWhenUsed="false" Name="Dark List Accent 3"/> UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/> UnhideWhenUsed="false" Name="Colorful List Accent 3"/> UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/> UnhideWhenUsed="false" Name="Light Shading Accent 4"/> UnhideWhenUsed="false" Name="Light List Accent 4"/> UnhideWhenUsed="false" Name="Light Grid Accent 4"/> UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/> UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/> UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/> UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/> UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/> UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/> UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/> UnhideWhenUsed="false" Name="Dark List Accent 4"/> UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/> UnhideWhenUsed="false" Name="Colorful List Accent 4"/> UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/> UnhideWhenUsed="false" Name="Light Shading Accent 5"/> UnhideWhenUsed="false" Name="Light List Accent 5"/> UnhideWhenUsed="false" Name="Light Grid Accent 5"/> UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/> UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/> UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/> UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/> UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/> UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/> UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/> UnhideWhenUsed="false" Name="Dark List Accent 5"/> UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/> UnhideWhenUsed="false" Name="Colorful List Accent 5"/> UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/> UnhideWhenUsed="false" Name="Light Shading Accent 6"/> UnhideWhenUsed="false" Name="Light List Accent 6"/> UnhideWhenUsed="false" Name="Light Grid Accent 6"/> UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/> UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/> UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/> UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/> UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/> UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/> UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/> UnhideWhenUsed="false" Name="Dark List Accent 6"/> UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/> UnhideWhenUsed="false" Name="Colorful List Accent 6"/> UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/> UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/> UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/> UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/> UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/> UnhideWhenUsed="false" QFormat="true" Name="Book Title"/> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Calibri"; "sans-serif"; }
Product Gene Name

NDP recombinant protein

[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
TOP
Sequence
MGSSHHH HHHSSGLVPR GSH MGSKTD SSFIMDSDPR RCMR HHYVDSISHP LYKCSSKMVL LARCEGHCSQ ASRSEPLVSF STVLKQPFRS SCHCCRPQTS KLKALRLRCS GGMRLTATYR YILSCHCEEC NS.
OMIM
300658
3D Structure
ModBase 3D Structure for Q00604
Host
E Coli
Purity/Purification
Greater than 80.0% as determined by SDS-PAGE.
Form/Format
800x600 The NDP solution (0.5mg/ml) contains 20mM Tris-HCl buffer (pH 8.0), 0.4M Urea and 10% glycerol.
Sterile Filtered colorless solution.
Preparation and Storage
Store at 4 degree C if entire vial will be used within 2-4 weeks. Store, frozen at -20 degree C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Avoid multiple freeze-thaw cycles.
Other Notes
Small volumes of NDP recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
TOP
Related Product Information for
NDP recombinant protein
Description: NDP Human Recombinant produced in E Coli is a single, non-glycosylated polypeptide chain containing 132 amino acids (25-133) and having a molecular mass of 14.8 kDa.NDP is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. Normal 0 false false false EN-US X-NONE HE MicrosoftInternetExplorer4 DefSemiHidden="true" DefQFormat="false" DefPriority="99" LatentStyleCount="267"> UnhideWhenUsed="false" QFormat="true" Name="Normal"/> UnhideWhenUsed="false" QFormat="true" Name="heading 1"/> UnhideWhenUsed="false" QFormat="true" Name="Title"/> UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/> UnhideWhenUsed="false" QFormat="true" Name="Strong"/> UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/> UnhideWhenUsed="false" Name="Table Grid"/> UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/> UnhideWhenUsed="false" Name="Light Shading"/> UnhideWhenUsed="false" Name="Light List"/> UnhideWhenUsed="false" Name="Light Grid"/> UnhideWhenUsed="false" Name="Medium Shading 1"/> UnhideWhenUsed="false" Name="Medium Shading 2"/> UnhideWhenUsed="false" Name="Medium List 1"/> UnhideWhenUsed="false" Name="Medium List 2"/> UnhideWhenUsed="false" Name="Medium Grid 1"/> UnhideWhenUsed="false" Name="Medium Grid 2"/> UnhideWhenUsed="false" Name="Medium Grid 3"/> UnhideWhenUsed="false" Name="Dark List"/> UnhideWhenUsed="false" Name="Colorful Shading"/> UnhideWhenUsed="false" Name="Colorful List"/> UnhideWhenUsed="false" Name="Colorful Grid"/> UnhideWhenUsed="false" Name="Light Shading Accent 1"/> UnhideWhenUsed="false" Name="Light List Accent 1"/> UnhideWhenUsed="false" Name="Light Grid Accent 1"/> UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/> UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/> UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/> UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/> UnhideWhenUsed="false" QFormat="true" Name="Quote"/> UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/> UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/> UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/> UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/> UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/> UnhideWhenUsed="false" Name="Dark List Accent 1"/> UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/> UnhideWhenUsed="false" Name="Colorful List Accent 1"/> UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/> UnhideWhenUsed="false" Name="Light Shading Accent 2"/> UnhideWhenUsed="false" Name="Light List Accent 2"/> UnhideWhenUsed="false" Name="Light Grid Accent 2"/> UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/> UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/> UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/> UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/> UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/> UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/> UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/> UnhideWhenUsed="false" Name="Dark List Accent 2"/> UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/> UnhideWhenUsed="false" Name="Colorful List Accent 2"/> UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/> UnhideWhenUsed="false" Name="Light Shading Accent 3"/> UnhideWhenUsed="false" Name="Light List Accent 3"/> UnhideWhenUsed="false" Name="Light Grid Accent 3"/> UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/> UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/> UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/> UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/> UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/> UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/> UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/> UnhideWhenUsed="false" Name="Dark List Accent 3"/> UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/> UnhideWhenUsed="false" Name="Colorful List Accent 3"/> UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/> UnhideWhenUsed="false" Name="Light Shading Accent 4"/> UnhideWhenUsed="false" Name="Light List Accent 4"/> UnhideWhenUsed="false" Name="Light Grid Accent 4"/> UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/> UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/> UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/> UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/> UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/> UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/> UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/> UnhideWhenUsed="false" Name="Dark List Accent 4"/> UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/> UnhideWhenUsed="false" Name="Colorful List Accent 4"/> UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/> UnhideWhenUsed="false" Name="Light Shading Accent 5"/> UnhideWhenUsed="false" Name="Light List Accent 5"/> UnhideWhenUsed="false" Name="Light Grid Accent 5"/> UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/> UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/> UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/> UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/> UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/> UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/> UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/> UnhideWhenUsed="false" Name="Dark List Accent 5"/> UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/> UnhideWhenUsed="false" Name="Colorful List Accent 5"/> UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/> UnhideWhenUsed="false" Name="Light Shading Accent 6"/> UnhideWhenUsed="false" Name="Light List Accent 6"/> UnhideWhenUsed="false" Name="Light Grid Accent 6"/> UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/> UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/> UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/> UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/> UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/> UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/> UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/> UnhideWhenUsed="false" Name="Dark List Accent 6"/> UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/> UnhideWhenUsed="false" Name="Colorful List Accent 6"/> UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/> UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/> UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/> UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/> UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/> UnhideWhenUsed="false" QFormat="true" Name="Book Title"/> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Calibri","sans-serif";}

Introduction: Norrie Disease (NDP) is a secreted regulatory protein which activates the canonical Wnt signaling pathway through FZD4 and LRP5 coreceptor. NDP takes part in retinal vascularization by acting as a ligand for FZD4 which signals through stabilizing beta-catenin (CTNNB1) and activating LEF/TCF-mediated transcriptional programs. NDP is involved in a pathway that regulates neural cell differentiation and proliferation and also in neuroectodermal cell-cell interaction.
Product Categories/Family for NDP recombinant protein
RECOMBINANT & NATURAL PROTEINS; Recombinant Proteins
NCBI/Uniprot data below describe general gene information for NDP. It may not necessarily be applicable to this product.
NCBI GI #
4557789
NCBI GeneID
4693
NCBI Accession #
NP_000257.1 [Other Products]
NCBI GenBank Nucleotide #
NM_000266.3 [Other Products]
UniProt Primary Accession #
Q00604 [Other Products]
UniProt Secondary Accession #
Q5JYH5; B2R8K6[Other Products]
UniProt Related Accession #
Q00604[Other Products]
Molecular Weight
15,044 Da
TOP
NCBI Official Full Name
norrin
NCBI Official Synonym Full Names
Norrie disease (pseudoglioma)
NCBI Official Symbol
NDP??[Similar Products]
NCBI Official Synonym Symbols
ND; EVR2; FEVR
??[Similar Products]
NCBI Protein Information
norrin; X-linked exudative vitreoretinopathy 2 protein; norrie disease protein
UniProt Protein Name
Norrin
UniProt Synonym Protein Names
Norrie disease protein; X-linked exudative vitreoretinopathy 2 protein
Protein Family
Norrin
UniProt Gene Name
NDP??[Similar Products]
UniProt Synonym Gene Names
EVR2??[Similar Products]
UniProt Entry Name
NDP_HUMAN
TOP
NCBI Summary for NDP
This gene encodes a secreted protein with a cystein-knot motif that activates the Wnt/beta-catenin pathway. The protein forms disulfide-linked oligomers in the extracellular matrix. Mutations in this gene result in Norrie disease and X-linked exudative vitreoretinopathy. [provided by RefSeq, Feb 2009]
TOP
UniProt Comments for NDP
NDP: Activates the canonical Wnt signaling pathway through FZD4 and LRP5 coreceptor. Plays a central role in retinal vascularization by acting as a ligand for FZD4 that signals via stabilizing beta-catenin (CTNNB1) and activating LEF/TCF-mediated transcriptional programs. Acts in concert with TSPAN12 to activate FZD4 independently of the Wnt-dependent activation of FZD4, suggesting the existence of a Wnt-independent signaling that also promote accumulation the beta-catenin (CTNNB1). May be involved in a pathway that regulates neural cell differentiation and proliferation. Possible role in neuroectodermal cell-cell interaction. Defects in NDP are the cause of Norrie disease (ND); also known as atrophia bulborum hereditaria or Episkopi blindness. ND is a recessive disorder characterized by very early childhood blindness due to degenerative and proliferative changes of the neuroretina. Approximately 50% of patients show some form of progressive mental disorder, often with psychotic features, and about one-third of patients develop sensorineural deafness in the second decade. In addition, some patients have more complex phenotypes, including growth failure and seizure. Defects in NDP are the cause of vitreoretinopathy exudative type 2 (EVR2). EVR2 is a disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery.

Protein type: Secreted; Secreted, signal peptide

Chromosomal Location of Human Ortholog: Xp11.4

Cellular Component: extracellular matrix; extracellular space; cell surface

Molecular Function: protein binding; protein homodimerization activity; growth factor activity; frizzled binding; cytokine activity

Biological Process: nervous system development; cell proliferation; Wnt receptor signaling pathway; sensory perception of sound; cell-cell signaling; visual perception; positive regulation of transcription, DNA-dependent; positive regulation of transcription factor activity; Wnt receptor signaling pathway through beta-catenin; signal transduction; placenta development; vacuole organization and biogenesis

Disease: Exudative Vitreoretinopathy 2, X-linked; Norrie Disease
Research Articles on NDP
1. Norrin induces the formation of a ternary complex with Fz4 and Lrp5/6 by binding to their respective extracellular domains
TOP
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
TOP
TOP
產(chǎn)品留言
標(biāo)題
聯(lián)系人
聯(lián)系電話
內(nèi)容
驗(yàn)證碼
點(diǎn)擊換一張
注:1.可以使用快捷鍵Alt+S或Ctrl+Enter發(fā)送信息!
2.如有必要,請(qǐng)您留下您的詳細(xì)聯(lián)系方式!
相關(guān)產(chǎn)品
PDGF-AA, ELISA Kit
PDGF-AA, ELISA Kit
PDGF-AA, ELISA Kit
PDGF-AA, ELISA Kit
PDGF-AA, ELISA Kit
PDGF-AA, ELISA Kit
PDGF-AA, ELISA Kit
Microphthalmia Associated Transcription Factor (MITF), ELISA Kit
microphthalmia-associated transcription factor, Polyclonal Antibody
CYP1B1, Polyclonal Antibody
CYP1B1, Polyclonal Antibody
CYP1B1, Blocking Peptide
CYP1B1, Polyclonal Antibody
CYP1B1, Polyclonal Antibody
CYP1B1, Polyclonal Antibody
CYP1B1, Polyclonal Antibody
CYP1B1, Polyclonal Antibody
CYP1B1, Antibody
CYP1B1, Polyclonal Antibody
CYP1B1, Polyclonal Antibody
CYP1B1, cDNA Clone
CYP1B1, Antibody
Cytochrome P450 1B1, Antibody
Cytochrome P450 1B1, Polyclonal Antibody
Cytochrome P450 1B1, Polyclonal Antibody
Cytochrome P450 1B1, Antibody
Cytochrome P450 1B1, Antibody
Cytochrome P450 1B1 (CYP1B1), Polyclonal Antibody
Cytochrome P450 1B1 (CYP1B1), Polyclonal Antibody
Cytochrome P450 1B1 (CYP1B1), Polyclonal Antibody
Cytochrome P450 1B1 (CYP1B1), Polyclonal Antibody
Cytochrome P450 1B1 (CYP1B1), Polyclonal Antibody
Cytochrome P450 1B1 (CYP1B1), Polyclonal Antibody
Cytochrome P450 1B1 (CYP1B1), ELISA Kit
Cytochrome P450 1B1 (CYP1B1), ELISA Kit
Cytochrome P450 1B1 (CYP1B1), ELISA Kit
Cytochrome P450 1B1 (CYP1B1), ELISA Kit
Cytochrome P450 1B1 (CYP1B1), Antibody Pair Kit
Cytochrome P450 1B1 (CYP1B1), Active Protein
Cytochrome P450 1B1 (CYP1B1), Polyclonal Antibody
Cytochrome P450 1B1 (CYP1B1), RTU ELISA Kit
Cytochrome P450 1B1 (CYP1B1), Recombinant Protein
Optineurin, Polyclonal Antibody
AGPAT2, Polyclonal Antibody
AGPAT2, cDNA Clone
AGPAT2, cDNA Clone
AGPAT2, Polyclonal Antibody
AGPAT2, Polyclonal Antibody
AGPAT2, Blocking Peptide
AGPAT2, cDNA Clone

滬公網(wǎng)安備 31011202007343號(hào)